Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-12

Clinical Trial Update: Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 study evaluating photodynamic therapy with methyl aminolevulinate cream for acne vulgaris in skin types IV/V completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methyl aminolevulinate cream (MAL, Metvix) (methyl aminolevulinate)

Snippet

Sponsor: Photocure | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2013-07-12